SLV310, a novel, potential antipsychotic, combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition

Rolf van Hes, Pieter Smid, Cees N. J. Stroomer, Koos Tipker, M.Th.M. Tulp, J.A.M. van der Heyden, Andrew C. McCreary, M.B. Hesselink, Chris G. Kruse

Bioorganic & Medicinal Chemistry Letters · 2003 · 27 citations · 8 references

DOIFull text

Open access

Concepts

References

8